Doxorubicin is a chemotherapy drug used commonly in women who have undergone surgery for breast cancer to prevent recurrent cancer. Although it...
READ MOREAcupuncture-like Stimulation
by Mike Ecclestone | Dec 3, 2020 | Funded Projects
The study was completed. 71 eligible subjects with a median age of 52 (range: 40-87) were randomized to ALTENS (n=35) and control (n=36). At 12...
READ MOREComprehensive Genomic Characteristics
by Mike Ecclestone | Nov 28, 2020 | Funded Projects
Triple negative breast cancer (TNBC) refers to tumours where the estrogen receptor (ER) and progesterone receptor are negative. In addition,...
READ MORERecent Posts
- Remote monitoring and virtual care in breast cancer (remote-BC), randomized phase II study
- A population-level approach for implementing rehabilitation for individuals with breast cancer at the Juravinski Cancer Centre: a feasibility trial
- Tumour-informed ctDNA detection in high-risk early breast cancer: a pilot feasibility study
- Co-design, implementation, and mixed-methods evaluation of a theory
- Radiation omission in patients with clinically node negative
Recent Comments